Saturday, May 7, 2022

Juniper acquires infigratinib rights from Helsinn in emerging markets | BioWorld

“Juniper Biologics is focused on therapy areas in which we can make the most difference – oncology, gene therapy and rare/orphan diseases,” a ...

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...